Abstract
e23241Background: Recent clinical trials have shown that immune-checkpoint blockade yields remarkable response in different carcinomas. However, the role of PD-L1 expression in breast cancer patien...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
